HK1104235A1 - S-mirtazapine for the treatment of hot flush - Google Patents

S-mirtazapine for the treatment of hot flush

Info

Publication number
HK1104235A1
HK1104235A1 HK07112680.3A HK07112680A HK1104235A1 HK 1104235 A1 HK1104235 A1 HK 1104235A1 HK 07112680 A HK07112680 A HK 07112680A HK 1104235 A1 HK1104235 A1 HK 1104235A1
Authority
HK
Hong Kong
Prior art keywords
mirtazapine
treatment
hot flush
flush
hot
Prior art date
Application number
HK07112680.3A
Other languages
English (en)
Inventor
Bm Bernardus Peeters
Anton Egbert Peter Adang
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1104235(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1104235A1 publication Critical patent/HK1104235A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK07112680.3A 2004-11-15 2007-11-21 S-mirtazapine for the treatment of hot flush HK1104235A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (fr) 2004-11-15 2005-11-14 S-mirtazapine pour le traitement des bouffées de chaleur

Publications (1)

Publication Number Publication Date
HK1104235A1 true HK1104235A1 (en) 2008-01-11

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07112680.3A HK1104235A1 (en) 2004-11-15 2007-11-21 S-mirtazapine for the treatment of hot flush

Country Status (31)

Country Link
US (4) US20070265245A1 (fr)
EP (1) EP1814555B1 (fr)
JP (1) JP2008519810A (fr)
KR (1) KR20070085470A (fr)
CN (2) CN102772414A (fr)
AR (1) AR053780A1 (fr)
AT (1) ATE439843T1 (fr)
AU (1) AU2005303778B2 (fr)
BR (1) BRPI0517818A2 (fr)
CA (1) CA2587283C (fr)
CY (1) CY1110538T1 (fr)
DE (1) DE602005016141D1 (fr)
DK (1) DK1814555T3 (fr)
ES (1) ES2329815T3 (fr)
HK (1) HK1104235A1 (fr)
HR (1) HRP20090513T1 (fr)
IL (1) IL182767A (fr)
MX (1) MX2007005827A (fr)
MY (1) MY144089A (fr)
NO (1) NO20072285L (fr)
NZ (1) NZ554858A (fr)
PE (1) PE20061051A1 (fr)
PL (1) PL1814555T3 (fr)
PT (1) PT1814555E (fr)
RS (1) RS51138B (fr)
RU (1) RU2396957C2 (fr)
SI (1) SI1814555T1 (fr)
TW (1) TW200631584A (fr)
UA (1) UA88655C2 (fr)
WO (1) WO2006051111A1 (fr)
ZA (1) ZA200703884B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1898919A2 (fr) * 2005-06-27 2008-03-19 N.V. Organon Procede de traitement de symptomes vasomoteurs induits par la depletion hormonale
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
WO2007101832A1 (fr) * 2006-03-06 2007-09-13 N.V. Organon Méthode perfectionnée pour sevrer d'un traitement hormonal de symptômes vasomoteurs induits par un épuisement hormonal
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte
RU2019143572A (ru) * 2017-05-25 2021-06-25 Глитек Ллс. Композиции для лечения посттравматического стрессового расстройства

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
PT1067934E (pt) * 1998-04-02 2004-03-31 Akzo Nobel Nv Solucao anti-depressiva liquida oral

Also Published As

Publication number Publication date
DK1814555T3 (da) 2009-12-07
ES2329815T3 (es) 2009-12-01
US20100267694A1 (en) 2010-10-21
AR053780A1 (es) 2007-05-23
CN102772414A (zh) 2012-11-14
RU2007122391A (ru) 2008-12-20
CN101056641A (zh) 2007-10-17
CA2587283C (fr) 2013-01-15
KR20070085470A (ko) 2007-08-27
RS51138B (sr) 2010-10-31
NZ554858A (en) 2009-10-30
EP1814555B1 (fr) 2009-08-19
EP1814555A1 (fr) 2007-08-08
AU2005303778A1 (en) 2006-05-18
JP2008519810A (ja) 2008-06-12
BRPI0517818A2 (pt) 2010-03-16
US20130225559A1 (en) 2013-08-29
TW200631584A (en) 2006-09-16
UA88655C2 (ru) 2009-11-10
IL182767A (en) 2011-07-31
AU2005303778B2 (en) 2011-02-17
MX2007005827A (es) 2007-07-20
WO2006051111A1 (fr) 2006-05-18
ZA200703884B (en) 2009-07-29
CY1110538T1 (el) 2015-04-29
IL182767A0 (en) 2007-09-20
SI1814555T1 (sl) 2009-12-31
NO20072285L (no) 2007-06-13
PT1814555E (pt) 2009-09-30
ATE439843T1 (de) 2009-09-15
RU2396957C2 (ru) 2010-08-20
DE602005016141D1 (de) 2009-10-01
US20120302552A1 (en) 2012-11-29
CA2587283A1 (fr) 2006-05-18
PL1814555T3 (pl) 2010-01-29
HRP20090513T1 (en) 2009-10-31
PE20061051A1 (es) 2006-10-26
MY144089A (en) 2011-08-15
US20070265245A1 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
HK1104235A1 (en) S-mirtazapine for the treatment of hot flush
GB2430152C (en) Shower arrangement
AU304111S (en) Lavatory
GB0417481D0 (en) Combination therapy
AU303668S (en) Lavatory
GB0517387D0 (en) Combinations for the treatment of cancer
GB0424339D0 (en) Combination therapy
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0400802D0 (en) Compounds for the treatment of disease
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0426141D0 (en) Treatment
ZA200606780B (en) Compounds for the treatment of diseases
HUP0401379A3 (en) Process for the preparation of risperidon
GB0405228D0 (en) Bathing aid
GB0517386D0 (en) Combinations for the treatment of cancer
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
IL179092A0 (en) Spiroderivatives for the treatment of hypertension
GB0415352D0 (en) Compounds for the treatment of disease
ZA200410080B (en) Composition for the treatment of humans
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121114